MGH International Skin of Color Lecture Series

 

 

This course is intended for dermatologists as well as healthcare providers of all backgrounds and specialties seeking to improve their diagnosis and management of skin conditions in diverse skin types and to grow in their practice of culturally competent medicine.

In addition to the core skin of color dermatology curriculum, which teaches the foundation of the diagnosis and management of skin conditions presenting in diverse skin types, this course also offers several specialized elective modules focused on current issues such as the impact of climate change and COVID infection on the skin, and hot topics in men’s health and cosmetics in skin of color.

Pricing

Physicians and Doctoral-level Professionals: $445.00
Other Professionals: $445.00
Students & Residents: $100.00

Specialty Modules

Specialty Modules:
AMA PRA Category 1 Credits™ per module
All Participants: $35 per module

Sign up for additional modules to enhance your educational experience. Click on the titles below to learn more!

Cancellation Policy

Refunds may be issued up two weeks after registration. An administrative fee of $25.00 will be deducted from your refund. Please email us at mghcme@mgh.harvard.edu with questions or concerns.

Restriction on Use of Materials

This site is operated and maintained by The Massachusetts General Hospital Psychiatry Academy. No material or information from this site may be copied, reproduced, republished, uploaded, posted, transmitted or distributed unless approved in writing by The Psychiatry Academy. Questions concerning the proper use of materials and information in this site should be directed to: mghcme@mgh.harvard.edu. No rights or licenses of any kind of The Psychiatry Academy’s intellectual property are transferred to, granted to, provided to or received by you as a result of using this web site.

Target Audience

This course is intended for dermatologists as well as healthcare providers of all backgrounds and specialties seeking to improve their diagnosis and management of skin conditions in diverse skin types as well as grow in their practice of culturally competent medicine.

Learning Objectives

By the end of this program, participants will be able to:

Neera Nathan, MD, MSHS - Skin Cancer in Diverse Skin Types

  • Identify the environmental and genetic risks factors of the non-melanoma and melanoma skin cancer in people with darker skin types
  • Describe the presentation of non-melanoma and melanoma skin cancer in people with darker skin types
  • Discuss barriers to care for preventing and managing skin cancer in people with darker skin types in addition to strategies to improve patient outcomes

Steven Chen, MD, MPH - Urgent and Emergent Rashes in Darker Skin Types

  • Analyze and properly initiate management of a new potentially severe cutaneous eruption in the hospitalized patient with darker skin.
  • Identify the salient clinical features to avoid missing a severe rash, such as SJS/TEN, DRESS, AGEP, purpura fulminans, especially in darker skin types.
  • Analyze available patient characteristics and data to identify culprit drugs when faced with an adverse skin reaction to medication.

Sandy Tsao, MD - Dark spots and Light Spots - Hyperpigmentation and Hypopigmentation

  •  Review some of the most common pigmentary disorders
  •  Review diagnostic tools available in the diagnosis and management of these disorders
  •  Discuss patient and treatment selection to maximize benefits and limit potential side effects

Pearl Grimes, MD - Vitiligo Crash Course

  • Identify the pathophysiology of vitiligo
  • Learn differentiating factors for conditions which appear similar to vitiligo
  • Identify clinical features, the role of biopsy and common laboratory assessments for vitiligo 
  • Identify the three pillars of therapeutic interventions: stabilization, repigmentation and maintenance to improve outcomes for patients with vitiligo

Amy McMichael, MD - Hair Disorders - Work up

  • Identify literature on hyperpigmentation, keloids and acne in skin of color
  • Discuss the current treatment options for skin disease in patients of color
  • Describe the pitfalls of treatment of skin disease in patients of color

Amy McMichael, MD - Hair Disorders – Management

  • Identify the most current updates in the diagnosis and treatment of hair and scalp disorders
  • Identify the most common forms of hair loss affecting African American patients
  • Demonstrate subtle and newly described factors that impact diagnosis and treatment of hair loss in patients of color

Rashmi Sarkar, MD,FAMS - Melasma - Work up and Management

  • Identify and classify melasma clinically
  • Analyze different facial hyperpigmentary disorders and describe their histopathological, dermoscopic features while differentiating them from melasma
  • Create a treatment plan for a melasma patient based on clinical severity

Donald Glass, MD, PhD - Keloid and Scars - Crash Course

  • Identify factors important in assessing risk for keloid development
  • Assess which treatment modalities are appropriate for keloids vs hypertrophic scars
  • Utilize different modalities to minimize pain in administering intralesional injections

Elena Hawryluk, MD, PhD - Pediatric Conditions

  • Provide management strategies for common pediatric dermatologic conditions in skin of color 
  • Identify the clinical presentation of common pediatric dermatologic conditions in skin of color 
  • Discuss culturally relevant skin products and environmental exposures for pediatric patients

Sandy Tsao, MD - Approaching Lasers and Procedures in Skin of Color

  •  Review key factors in evaluating the aging patient
  • Review treatment options available for improvement of photoaging
  • Discuss patient and treatment selection to maximize cosmetic outcomes

Susan Taylor, MD - Skin care and Cosmeceuticals in Skin of Color

  • Describe key structural and functional differences between skin of color and white skin
  • Predict appropriate cosmeceutical agents for the treatment of dyspigmentation in skin of color patients
  • Discuss appropriate therapeutic choices for the treatment of acne in skin of color patients

Course summary
Available credit: 
  • 6.00 AMA PRA Category 1 Credit™

    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of McLean Hospital and Massachusetts General Hospital. McLean Hospital is accredited by the ACCME to provide continuing medical education for physicians.

    McLean Hospital designates this Enduring activity for a maximum of 6.00 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

  • 6.00 Nursing Contact Hours

    Massachusetts General Laws, Chapter 13, sections 13, 14, 14A, 15 and 15D and Chapter 112, sections 74 through 81C authorize the Board of Registration in Nursing to regulate nursing practice and education.

    This program meets the requirements of the Massachusetts Board of Registration in Nursing (244 CMR 5.00) for 6.00 contact hours of nursing continuing education credit. Advance practice nurses, please note: Educational activities which meet the requirements of the ACCME (such as this activity) count towards 50% of the nursing requirement for ANCC accreditation.

  • 6.00 Participation

    This course allows other providers to claim a Participation Certificate upon successful completion of this course.

    Participation Certificates will specify the title, location, type of activity, date of activity, and number of AMA PRA Category 1 Credit™ associated with the activity. Providers should check with their regulatory agencies to determine ways in which AMA PRA Category 1 Credit™ may or may not fulfill continuing education requirements. Providers should also consider saving copies of brochures, agenda, and other supporting documents.

Registration opens: 
12/01/2021
Course closes: 
04/18/2026
Cost:
$445.00
Rating: 
0

MGH International Skin of Color Lecture Series

Week 1

Skin Cancer in Diverse Skin Types
Neera Nathan, MD, MSHS

Urgent and Emergent Rashes in Darker Skin Types
Steven Chen, MD, MPH

Week 2

Dark spots and Light Spots - Hyperpigmentation and Hypopigmentation
Sandy Tsao, MD

Vitiligo Crash Course
Pearl Grimes, MD

Week 3

Hair Disorders - Work up
Amy McMichael, MD

Hair Disorders - Management
Amy McMichael, MD

Week 4

Melasma - Work up and Management
Rashmi Sarkar, MD, FAMS

Keloid and Scars - Crash Course
Donald Glass, MD, PhD

Week 5

Pediatric Conditions 
Elena Hawryluk, MD, PhD

Week 6

Approaching Lasers and Procedures in Skin of Color
Sandy Tsao, MD

Skin care and Cosmeceuticals in Skin of Color
Susan Taylor, MD

Speaker(s)

Steven Chen, MD, MPH, MS-HPEd

has a financial relationship (Professional Services) with VisualDx;.

Pearl Grimes, MD

has no relevant financial relationships to disclose at this time.

Amy McMichael, MD

has no relevant financial relationships to disclose at this time.

Neera Nathan, MD, MSHS

has no relevant financial relationships to disclose at this time.

Rashmi Sarkar, MD, FAMS

has no relevant financial relationships to disclose at this time.

Sandy Tsao, MD

has no relevant financial relationships to disclose at this time.

Available Credit

  • 6.00 AMA PRA Category 1 Credit™

    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of McLean Hospital and Massachusetts General Hospital. McLean Hospital is accredited by the ACCME to provide continuing medical education for physicians.

    McLean Hospital designates this Enduring activity for a maximum of 6.00 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

  • 6.00 Nursing Contact Hours

    Massachusetts General Laws, Chapter 13, sections 13, 14, 14A, 15 and 15D and Chapter 112, sections 74 through 81C authorize the Board of Registration in Nursing to regulate nursing practice and education.

    This program meets the requirements of the Massachusetts Board of Registration in Nursing (244 CMR 5.00) for 6.00 contact hours of nursing continuing education credit. Advance practice nurses, please note: Educational activities which meet the requirements of the ACCME (such as this activity) count towards 50% of the nursing requirement for ANCC accreditation.

  • 6.00 Participation

    This course allows other providers to claim a Participation Certificate upon successful completion of this course.

    Participation Certificates will specify the title, location, type of activity, date of activity, and number of AMA PRA Category 1 Credit™ associated with the activity. Providers should check with their regulatory agencies to determine ways in which AMA PRA Category 1 Credit™ may or may not fulfill continuing education requirements. Providers should also consider saving copies of brochures, agenda, and other supporting documents.

 
Status
Price
Title
$445.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.

Price

Cost:
$445.00
Please login or register to take this course.

Release Date: 2/7/2022
Expiration Date: 4/18/2026

Course Director(s)

Shadi Kourosh, MD

Planners

Shadi Kourosh, MD
David H. Rubin, MD, reviewer
Susan E. Sprich, PhD, psychologist reviewer, moderator
Jane Pimental, MPH

Disclosure Information 

In accord with the disclosure policy of McLean Hospital as well as guidelines set forth by the Accreditation Council on Continuing Medical Education, all people in control of educational content, including speakers, course directors, planners, and reviewers, have been asked to disclose all financial relationships with ineligible companies for the past 24 months, as defined below:             

Ineligible Companies 

The ACCME defines an “Ineligible company” as “those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.”  For more information, visit

accme.org/standards

Financial Relationships

Financial relationships are those relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit.  Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected. 

Mitigation of Financial Relationships

All financial relationships are reviewed to determine which ones are relevant, and then measures are taken to mitigate all relevant financial relationships and ensure that they do not insert commercial bias into the content of the education.   

The following planners, speakers, content reviewers, and others in control of educational content have reported financial relationships with ineligible companies over the past 24 months. Measures have been taken to mitigate the impact of these financial relationships on the educational content and ensure that they do not insert commercial bias into the content of this education.  

Susan Sprich, PhD
Royalties (Co-Author): Oxford University Press
Royalties (Co-Edited Book): Springer
Honoraria (Associate Editors): Association for Behavioral and Cognitive Therapies (ABCT)

Steven Chen, MD, MPH
Consultant (Social Media): Pfizer; Novartis

Hassan Galadari, MD, FAAD
Consultant: Revance Therapeutics; Merz Aesthetics; Matex Labs
Speaker: Beiersdorf
Speaker/Consultant: Fillmed Laboratories

Donald Glass, MD, PhD
Consultant: Thirona
Advisor: Pfizer; AbbVie

Pearl Grimes, MD
Consultant/Researcher: Incyte; Skin Better Science; L'Oreal
Consultant, Researcher, Stakeholder: Versicolor Technologies
Consultant: Laser Optics; Galderma; Abbvie/Allergan
Researcher: Pfizer; Aventis

Evangeline B. Handog, FPDS, FPADSFI, FAAD
Speaker: Galderma
Speaker: Brady

Elena Hawryluk, MD, PhD
Stock(Spouse Employment): Gritstone Oncology
Advisory Board(Spouse): PathAI
Author/Reviewer: UpToDate
Consultant: Purity Brands LLC

Amy McMichael, MD
Consultant: Allergan, Almirall, Arcutis, Bioniz, Cassiopea, Covance, eResearch Technology, Inc., Galderma, Incyte, Johnson & Johnson, Keranetics, Lilly, Merck & Co., Inc., Pfizer, Proctor & Gamble, Revian, Samumed
Grants: Allergan, Arcutis, Concert Pharmaceuticals, Proctor & Gamble    
Research: Cassiopea, Concert Pharmaceuticals, Incyte, Proctor & Gamble, Samumed
Royalties: Informa Healthcare, UpToDate

Jose F. Montes, MD
Consultant/Speaker: Allergan/Abbvie; Merz; Galderma; Obagi

Susan Taylor, MD
Advisory Board/Speaker/Consultant: Beiersdorf, Inc.
Advisory Board: Galderma Laboratories, LP
Investigator: Eli Lilly and Company
Board of Directors: CannTec
Speaker/Faculty Ed, Advisory Board: L'Oreal USA
Investigator: Pfizer; Concert Pharmaceuticals

All other individuals in a position to control the content of this educational activity have reported no financial relationships with ineligible companies.


Hardware/Software Specifications

This internet-based CME activity is best experienced using Internet Explorer 8+, Mozilla Firefox 3+, Safari 4+. This Web site requires that JavaScript and session cookies be enabled. Certain activities may require additional software to view multimedia, presentation, or printable versions of the content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Adobe Acrobat, Microsoft PowerPoint, and Windows Media Player.

Optimal System Configuration

Flash Player: Adobe Flash Player 10.1+
Browser: Firefox 3+, Internet Explorer 8.0+, Safari 4.0+, or Google Chrome 7.0+
Operating System: Windows XP+ or Mac OS X 10.4+
Internet Connection: 1 Mbps or higher

Minimum Requirements

Windows PC:500-MHz Pentium II; Windows XP or higher; 128 MB RAM; Video Card at least 64MB of video memory; Sound Card at least 16-bit; Macromedia Flash Player 10 or higher, audio playback with speakers for programs with video content; Firefox 1.1+, Internet Explorer 7.0+, Safari 1.0+, Google Chrome, or Opera
Macintosh: Mac OS X 10.3 or higher with latest updates installed; 1.83MHz Intel Core Duo or faster; RAM: 128MB or more; Video Card: at least 64MB of video memory; Sound Card: at least 16-bit


Privacy Policy

Please click here to review our privacy policy.